Form 13-F position report

CORBUS PHARMACEUTICALS HLDG

Reported by TIAA CREF INVESTMENT MANAGEMENT LLC

CRBP CUSIP 21833P103 Manager CIK 0000887793

Reported 124,228 shares, up 8,572 (7.4%) from the prior quarter.

Reported value -7.7%; share count 7.4% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q1 2018
Shares 124,228 Quarter-end amount reported
Reported value $758,000 Fair value at quarter end
Consecutive quarters held 4 Through Q1 2018

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2017-06-30 760000
2017-09-30 825000
2017-12-31 821000
2018-03-31 758000
2018-06-30 534000
2018-09-30 751000
2018-12-31 581000
2019-03-31 692000

Quarterly position history

How this manager's reported quarter-end position changed over time.

8 quarters
Quarterly reported position history for CORBUS PHARMACEUTICALS HLDG held by TIAA CREF INVESTMENT MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2019 Unchanged 99,525 0 (0.0%) < 0.01% $692,000 2019-05-14
Q4 2018 Unchanged 99,525 0 (0.0%) < 0.01% $581,000 2019-02-14
Q3 2018 Reduced 99,525 -6,295 (-5.9%) < 0.01% $751,000 2018-11-14
Q2 2018 Reduced 105,820 -18,408 (-14.8%) < 0.01% $534,000 2018-08-14
Q1 2018 Added 124,228 +8,572 (7.4%) < 0.01% $758,000 2018-05-14
Q4 2017 Added 115,656 +279 (0.2%) < 0.01% $821,000 2018-02-14
Q3 2017 Reduced 115,377 -5,185 (-4.3%) < 0.01% $825,000 2017-11-13
Q2 2017 New 120,562 +120,562 (0.0%) < 0.01% $760,000 2017-08-10

Who else reported the position

88 managers reported CORBUS PHARMACEUTICALS HLDG for Q1 2018.

Managers reporting CORBUS PHARMACEUTICALS HLDG in Q1 2018.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 4,387,188 +2,289,684 < 0.01% $26,762,000 6 qtrs
Knoll Capital Management LLC Unchanged 3,856,985 0 24.16% $23,528,000 12 qtrs
BlackRock Inc Added 3,648,352 +53,666 < 0.01% $22,256,000 5 qtrs
ETF MANAGERS GROUP LLC Added 2,456,921 +2,229,245 0.88% $14,496,000 2 qtrs
VANGUARD GROUP INC Added 2,161,309 +19,156 < 0.01% $13,184,000 12 qtrs
IFP Advisors Inc Unchanged 1,000,805 0 0.32% $7,106,000 9 qtrs
STATE STREET CORPORATION Added 797,146 +94,278 < 0.01% $4,861,000 7 qtrs
BAKER BROS ADVISORS LP Unchanged 660,714 0 0.03% $4,030,000 6 qtrs
MORGAN STANLEY Added 620,369 +60,474 < 0.01% $3,784,000 12 qtrs
NORTHERN TRUST CORPORATION Added 531,969 +7,815 < 0.01% $3,245,000 12 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2018
Filed
May 14, 2018
Filing type
13F-HR
Position type
CS

Voting authority reported

Sole
124,228
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.